| RS1653178441 |
DARS2
|
Health Risk |
Pathogenic |
— |
| RS1653192107 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS1653241392 |
ATP1A1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-tooth disease, axonal |
| RS1653248260 |
YARS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal degeneration, Hepatic steatosis |
| RS1653256261 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1653295871 |
CACNA1E
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 69 |
| RS1653321651 |
SZT2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 18 |
| RS1653324348 |
HMGCS2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1653326843 |
AGL
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1653335301 |
NECTIN4
|
Health Risk |
Pathogenic |
Ectodermal dysplasia-syndactyly syndrome 1, Ectodermal dysplasia-syndactyly syndrome 1 |
| RS1653396401 |
POGZ
|
Health Risk |
Pathogenic |
— |
| RS1653397845 |
POGZ
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1653397925 |
SZT2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 18 |
| RS1653448255 |
ATP1A1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-tooth disease, axonal |
| RS1653455584 |
POGZ
|
Health Risk |
Pathogenic |
Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome, Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome |
| RS1653497680 |
POGZ
|
Health Risk |
Likely pathogenic |
Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome, Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome |
| RS1653548589 |
SEMA4A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1653560615 |
POGZ
|
Health Risk |
Likely pathogenic |
Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome, Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome |
| RS1653579916 |
POGZ
|
Health Risk |
Pathogenic |
Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome, Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome |
| RS1653612721 |
SPTA1
|
Health Risk |
Pathogenic |
— |
| RS1653647344 |
POGZ
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS1653665864 |
SZT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1653728836 |
SPTA1
|
Health Risk |
Likely pathogenic |
— |
| RS1653759340 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1653766307 |
POGZ
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS1653770239 |
POGZ
|
Health Risk |
Pathogenic |
Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome, Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome |
| RS1653807656 |
POGZ
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS1653809027 |
POGZ
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS1653847504 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS1653872984 |
SPTA1
|
Health Risk |
Likely pathogenic |
SPTA1-related disorder, SPTA1-related disorder |
| RS1653916498 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS1653925536 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS1653935181 |
CTSK
|
Health Risk |
Pathogenic/Likely pathogenic |
Pyknodysostosis, Pyknodysostosis |
| RS1653935585 |
AGL
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1653938652 |
AGL
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1654007685 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS1654011638 |
POGZ
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS1654042476 |
CTSK
|
Health Risk |
Likely pathogenic |
Pyknodysostosis, Pyknodysostosis |
| RS1654043546 |
CTSK
|
Health Risk |
Pathogenic |
Pyknodysostosis, Pyknodysostosis |
| RS1654056152 |
POGZ
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS1654079662 |
CTSK
|
Health Risk |
Likely pathogenic |
Pyknodysostosis, Pyknodysostosis |
| RS1654079940 |
CTSK
|
Health Risk |
Pathogenic |
— |
| RS1654081712 |
POGZ
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome |
| RS1654082906 |
CTSK
|
Health Risk |
Pathogenic |
— |
| RS1654084368 |
SZT2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 18 |
| RS1654085401 |
CTSK
|
Health Risk |
Pathogenic/Likely pathogenic |
Pyknodysostosis, Pyknodysostosis |
| RS1654090648 |
CTSK
|
Health Risk |
Pathogenic |
— |
| RS1654101631 |
CTSK
|
Health Risk |
Likely pathogenic |
Pyknodysostosis, Pyknodysostosis |
| RS1654102585 |
CTSK
|
Health Risk |
Pathogenic |
Pyknodysostosis, Pyknodysostosis |
| RS1654108256 |
CASQ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Myopathy with tubular aggregates, Myopathy with tubular aggregates |
| RS1654199242 |
CASQ2
|
Health Risk |
Likely pathogenic |
— |
| RS1654250819 |
CASQ2
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1654497416 |
PACS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1654576202 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS1654652414 |
DPYD
|
Health Risk |
Likely pathogenic |
Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidine dehydrogenase deficiency |
| RS1654687449 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1654690647 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1654695322 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1654701324 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1654707104 |
CACNA1E
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 69 |
| RS1654707272 |
POGZ
|
Health Risk |
Pathogenic |
— |
| RS1654721399 |
CRB1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1654722291 |
CRB1
|
Health Risk |
Pathogenic |
— |
| RS1654722914 |
CRB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 12 |
| RS1654723466 |
CRB1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 8, Retinitis pigmentosa 12 |
| RS1654731473 |
SPTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1654732346 |
COL7A1
|
Health Risk |
Likely pathogenic |
Epidermolysis bullosa dystrophica, Epidermolysis bullosa dystrophica |
| RS1654782224 |
DPYD
|
Health Risk |
Likely pathogenic |
Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidine dehydrogenase deficiency |
| RS1654812809 |
SPTA1
|
Health Risk |
Pathogenic |
— |
| RS1654817532 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1654818141 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1654854600 |
SZT2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 18 |
| RS1654858951 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS1654902207 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1654908371 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1654912428 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1654921932 |
CD55
|
Health Risk |
Pathogenic |
— |
| RS1654941272 |
PTPRC
|
Health Risk |
Pathogenic/Likely pathogenic |
Immunodeficiency 104, Immunodeficiency 105 |
| RS1654968072 |
PIGK
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures |
| RS1655006399 |
CD46
|
Health Risk |
Likely pathogenic |
Atypical hemolytic-uremic syndrome, Atypical hemolytic-uremic syndrome |
| RS1655023196 |
PRRX1
|
Health Risk |
Likely pathogenic |
Agnathia-otocephaly complex, Agnathia-otocephaly complex |
| RS1655047525 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1655053800 |
KDM5B
|
Health Risk |
Likely pathogenic |
— |
| RS1655058321 |
KDM5B
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1655077098 |
NEK2
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1655079234 |
JAK1
|
Health Risk |
Likely pathogenic |
Acute megakaryoblastic leukemia in down syndrome, Acute megakaryoblastic leukemia in down syndrome |
| RS1655094479 |
SPTA1
|
Health Risk |
Likely pathogenic |
— |
| RS1655113495 |
TBX15
|
Health Risk |
Pathogenic |
— |
| RS1655117230 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1655117886 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1655124681 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1655125488 |
SZT2
|
Health Risk |
Likely pathogenic |
— |
| RS1655136943 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1655170724 |
SZT2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 18 |
| RS1655173102 |
JAK1
|
Health Risk |
Pathogenic |
Autoinflammation, immune dysregulation |
| RS1655201565 |
GLMN
|
Health Risk |
Likely pathogenic |
Glomuvenous malformation, Glomuvenous malformation |
| RS1655263308 |
CUBN
|
Health Risk |
Pathogenic |
Imerslund-Grasbeck syndrome, Imerslund-Grasbeck syndrome |
| RS1655275276 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS1655343130 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS1655379382 |
KDM5B
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal recessive 65 |